Expertise in
10
conditions

Dr. Michael J. Kaplan

Rheumatology
The St. Lukes Roosevelt Hospital Center
440 W 114th St, 
New York, NY 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
10
conditions
The St. Lukes Roosevelt Hospital Center
440 W 114th St, 
New York, NY 

Overview

Michael Kaplan is a Rheumatologist practicing medicine in New York, New York.

Dr. Kaplan is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Scleredema, Rheumatoid Arthritis (RA), Fibromyalgia, and Behcet Disease.

He is actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 4 clinical trials. Dr. Kaplan is currently accepting new patients.

Specialties

Rheumatology

Licenses

Hospitalist in NY

Hospital Affiliations

Mount Sinai West

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Northwell Health
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

The St. Lukes Roosevelt Hospital Center
440 W 114th St, New York, NY 10025
Other Locations
Manhattan Diagnostic Laboratory
425 W 59th St, New York, NY 10019

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy With the IRX 2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy With the IRX 2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Drug, Dietary supplement, Biological
Study Drugs: IRX-2, Cyclophosphamide, Indomethacin, Omeprazole
Study Phase: Phase 2
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures
Enrollment Status: Completed
Publish Date: September 24, 2021
Intervention Type: Drug, Device
Study Phase: Phase 1
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
Enrollment Status: Terminated
Publish Date: June 24, 2019
Intervention Type: Drug
Study Phase: Phase 1
Multispectral Imaging to Characterize Patterns of Vascular Supply Within the Lymphoepithelial Mucosa of Patients With Known or Suspected Oropharyngeal Carcinoma (OPC)
Multispectral Imaging to Characterize Patterns of Vascular Supply Within the Lymphoepithelial Mucosa of Patients With Known or Suspected Oropharyngeal Carcinoma (OPC)
Enrollment Status: Completed
Publish Date: March 01, 2019
View 3 Less Clinical Trials

32 Total Publications

89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 10, 2022
Similar Doctors
Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required
Before you request

HSS - Belaire Building

525 East 71st Street, 7th Floor, 
New York, NY 
 (2.8 miles away)
212-860-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Spiera is a Rheumatologist practicing medicine in New York, New York. Dr. Spiera is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Vasculitis, Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica. Dr. Spiera is currently accepting new patients.

Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required
Before you request

Hospital For Special Surgery-Main Hospital

535 E 70th St Fl 6, 
New York, NY 
 (2.5 miles away)
212-606-1163
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Susan Goodman is a Rheumatologist practicing medicine in New York, New York. Dr. Goodman is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, Knee Replacement, and Hip Replacement. Dr. Goodman is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required
Before you request

Belaire Building

525 E 71st St Fl 7, 
New York, NY 
 (2.5 miles away)
212-606-1173
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jessica Gordon is a Rheumatologist practicing medicine in New York, New York. Dr. Gordon is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Localized Scleroderma. Dr. Gordon is currently accepting new patients.

Frequently Asked Questions about Dr. Michael J. Kaplan

How do I make an appointment with Dr. Michael J. Kaplan?

You can book an appointment with Dr. Michael J. Kaplan by calling their office at 212-523-8672. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael J. Kaplan a top-rated expert for Scleredema?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael J. Kaplan is classified as an Advanced expert for Scleredema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael J. Kaplan specialize in?

While Dr. Michael J. Kaplan is a Rheumatology, they have specific expertise in Scleredema, Rheumatoid Arthritis (RA), and Fibromyalgia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Michael J. Kaplan participate in research or clinical trials?

Yes. Dr. Michael J. Kaplan has published 32 articles and abstracts on conditions like Scleredema. You can view a list of Dr. Michael J. Kaplan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael J. Kaplan accept my insurance?

Dr. Michael J. Kaplan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-523-8672 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kaplan's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 56 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile